Myriad Genetics Inc
MYGN· Nasdaq
MYGNMyriad Genetics Inc
Source filing unavailable
| Metric | Q1 2011 | Q1 2010 |
|---|---|---|
| Revenue | $91.86M | $85.12M |
| Net Income | $22.54M | $30.44M |
| EPS Diluted | $0.24 | $0.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Myriad Genetics Inc · CIK 899923 · Engraved from SEC EDGAR
